Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).

Read more in the app

A study of support groups (n=1276; 49 countries) concluded 71% found their doctors' advice unhelpful regarding stopping an antidepressant; the main reasons being a reduction rate that was too quick, the doctor not familiar with withdrawal symptoms or saying stoppings meds won't cause symptoms.

Humble tea’s antidepressant properties confirmed

Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression

Antidepressant use, infection during pregnancy linked to neurodevelopmental changes in babies, study suggests

Scientists Have Developed a New, Better Antidepressant

Effectively Reducing Stress and Treating Anxiety Disorders Without Antidepressant Drugs

The nose-brain pathway: Exploring the role of trigeminal nerves in delivering intranasally administered antidepressant

Mindfulness-based stress reduction is as effective as an antidepressant drug for treating anxiety disorders, study finds

Genetic Testing Could Help Doctors Choose Antidepressant Prescriptions

Changing the channel: Study sheds new light on a promising antidepressant

FDA Rejects Bid To Authorize Cheap Antidepressant As Covid Treatment

Antidepressant use during pregnancy not linked to epilepsy in children

Common Antidepressant Likely Cuts Risk Of Covid Hospitalization, Study Finds

In 2019, the European Medicine Agency finally concluded that antidepressant can have long lasting impact on sexual functioning even after discontinuation, this syndrome is referred to as PSSD (Post SSRI Sexual Dysfunction). (Page 5 of Link)

AI to predict antidepressant outcomes in youth

Pregnant Women Have Lingering Depression, Anxiety – Even With Antidepressant Treatment

Review reports improved transparency in antidepressant drug trials

Researchers identify biomarker for depression, antidepressant response

Common Antidepressant Slashes Risk of COVID Death

Low-Cost Antidepressant Fluvoxamine Saves Lives of COVID-19 Patients – “Powerful Weapon Against the Virus”